Soluble Receptor for Advanced Glycation End Products Improves Stromal Cell-Derived Factor-1 Activity in Model Diabetic Environments.

Olekson, Melissa Przyborowski; Faulknor, Renea A; Hsia, Henry C; Schmidt, Ann Marie; Berthiaume, François

Olekson, Melissa Przyborowski; Faulknor, Renea A; Hsia, Henry C; Schmidt, Ann Marie; Berthiaume, François.

Afiliación

Olekson MP; Department of Biomedical Engineering, Rutgers University , Piscataway, New Jersey.
Faulknor RA; Department of Biomedical Engineering, Rutgers University , Piscataway, New Jersey.
Hsia HC; Department of Surgery, Robert Wood Johnson Medical School, Rutgers University , New Brunswick, New Jersey.
Schmidt AM; Departments of Medicine, Pharmacology, and Pathology, New York University Medical Center , New York.
Berthiaume F; Department of Biomedical Engineering, Rutgers University , Piscataway, New Jersey.

Adv Wound Care (New Rochelle) ; 5(12): 527-538, 2016 Dec 01.

Article en En | MEDLINE | ID: mdl-28078186

Palabras clave

HL60 cells; advanced glycation end-products; cell migration; hyperglycemia; intracellular calcium; peripheral mononuclear white blood cells

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Adv Wound Care (New Rochelle) Año: 2016 Tipo del documento: Article